RGBP
Regen BioPharma Inc
Key Financials
Operating Income
$-338540
↑ 18.9%
Revenue
$126560
↑ 0.8%
EPS (Diluted)
$-0.05
↑ 68.8%
Shareholders' Equity
$-6281183.00
↓ 20.4%
Total Liabilities
$6.6M
↑ 21.9%
Cash & Equivalents
$69555.00
↑ 9614.4%
Operating Cash Flow
$-383591.00
↑ 49.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 5/14/2026 | View on SEC |
| 8-K | 3/4/2026 | View on SEC |
| 10-Q | 2/13/2026 | View on SEC |
| 8-K | 2/2/2026 | View on SEC |
| 8-K | 1/21/2026 | View on SEC |
| QUALIF | 1/12/2026 | View on SEC |
| 1-A POS | 1/8/2026 | View on SEC |
| 10-K | 12/30/2025 | View on SEC |
| 253G1 | 12/5/2025 | View on SEC |
| QUALIF | 12/3/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | RGBP |
| Company Name | Regen BioPharma Inc |
| CIK | 1589150 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | OTC |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 0930 |
| State of Incorporation | NV |
| Phone | 619-722-5505 |